1.46
0.31 (26.96%)
| Penutupan Terdahulu | 1.15 |
| Buka | 1.14 |
| Jumlah Dagangan | 1,583,165 |
| Purata Dagangan (3B) | 187,771 |
| Modal Pasaran | 14,133,187 |
| Harga / Jualan (P/S) | 0.130 |
| Harga / Buku (P/B) | 0.230 |
| Julat 52 Minggu |
| Margin Keuntungan | -294.05% |
| Margin Operasi (TTM) | -131.10% |
| EPS Cair (TTM) | -53.53 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -26.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 38.21% |
| Nisbah Semasa (MRQ) | 1.70 |
| Aliran Tunai Operasi (OCF TTM) | -43.55 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 4.19 M |
| Pulangan Atas Aset (ROA TTM) | -30.70% |
| Pulangan Atas Ekuiti (ROE TTM) | -127.82% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Bionano Genomics, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 2.0 |
| Purata | -1.13 |
|
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.06% |
| % Dimiliki oleh Institusi | 9.13% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Carret Asset Management, Llc | 31 Dec 2025 | 44,100 |
| R Squared Ltd | 31 Dec 2025 | 13,771 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies |
| 12 Jan 2026 | Pengumuman | Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |